CD15
免疫分型
病理
流式细胞术
淋巴
淋巴瘤
医学
CD20
生物
免疫学
川地34
遗传学
干细胞
作者
Jonathan R. Fromm,Anju Thomas,Brent L. Wood
出处
期刊:American Journal of Clinical Pathology
[Oxford University Press]
日期:2009-02-19
卷期号:131 (3): 322-332
被引量:106
标识
DOI:10.1309/ajcpw3un9dyldspb
摘要
Abstract The diagnosis of classical Hodgkin lymphoma (CHL) has been made in tissue sections as attempts to identify neoplastic Hodgkin and Reed Sternberg (HRS) cells in lymph nodes by flow cytometry (FC) have been unsuccessful. However, we have recently demonstrated that HRS cells can be identified by FC, often present as T-cell–HRS-cell rosettes. In this study, we examined the usefulness of a novel 9-color (CD95–Pacific blue/CD64–fluorescein isothiocyanate/CD30-phycoerythrin [PE]/CD45-PE–Texas red/CD40–PE cyanine [Cy]5.5/CD20-PECy7/CD15-allophycocyanin [APC]/CD71-APC–AlexaFluor A700/CD5-APC-Cy7), single tube FC assay to diagnose CHL in lymph nodes. We used the FC assay to determine diagnostic sensitivity and specificity in 279 blindly identified and 141 selected (for specimen type or cytopreparation morphologic features suggesting CHL) tissues. Of the 53 morphologically defined CHL cases identified (10 in the unselected group; 43 in the selected group), the FC assay diagnostic sensitivity and specificity were 88.7% and 100%, respectively. With the current availability of 8 (or more) color clinical flow cytometers, this assay can now be applied to routinely immunophenotype and confirm a diagnosis of CHL or as an adjunct to immunohistochemical analysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI